Fate Therapeutics (FATE)

Fate Therapeutics (FATE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• FATE last traded at $2.08, -4.15% on the day.
• Fate Therapeutics: market cap $249.23M, P/E -1.9, revenue $6.49M over the last four quarters, next earnings 2026-11-12.
• Over the past year FATE returned 61.24%; year to date 111.68%.

Updated 2026-11-02 18:24 UTC